semaglutide shortage fda Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list Semaglutide Injections and the FDA

MTA does not control or guarantee the clinical judgment, treatment decisions, services, or outcomes of independent healthcare providers

For example, if you currently have an approved prior authorization through Part D for Zepbound prescribed for moderate to severe sleep apnea, Wegovy for cardiovascular risk reduction or noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), or all FDA-approved medications for treating Type 2 Diabetes (Ozempic, Mounjaro, etc.), the Medicare GLP-1 Bridge program will not cover your medication

For users without obesity, these drugs may represent a means of achieving socially approved body shapes and social worth without the burden of traditional self-discipline

ISSN 0304-4165

J.BajramiB.RamosA